All About: Swine fever, Teva migraine drug, Baby-aspirin risks

Battling the spread of African swine fever in China is "very complex and challenging", the country's agriculture ministry said after chairing a meeting of over a dozen major government bodies.


Reuters | Updated: 17-09-2018 02:36 IST | Created: 17-09-2018 02:28 IST
All About: Swine fever, Teva migraine drug, Baby-aspirin risks
The meeting on Thursday came as more than a dozen African swine fever outbreaks have been reported across China since early August, mostly on small farms. (Image Credit: Twitter)

 

China says battling swine fever is 'complex and challenging'

Battling the spread of African swine fever in China is "very complex and challenging", the country's agriculture ministry said after chairing a meeting of over a dozen major government bodies. The meeting on Thursday came as more than a dozen African swine fever outbreaks have been reported across China since early August, mostly on small farms.

Australia to start powerful public inquiry into the aged-care sector

Australia will begin a public inquiry, or Royal Commission, into the country's aged-care sector as a spike in cases of elderly abuse creates a "disturbing trend", Prime Minister Scott Morrison said on Sunday. The inquiry comes at a time when the number of Australians moving into residential care is set to jump, with the population aged 65 years and above, according to official data, forecast to more than double to 8.9 million by 2055.

U.S. regulator approves Teva migraine drug, shares rise

Shares of Israeli drugmaker Teva Pharmaceutical Industries rose over 5 percent in after-hours trading on Friday after the U.S. Food and Drug Administration (FDA) approved the company's new migraine treatment, a drug Teva has been banking on to help revive its fortunes. The wholesale price of the drug, Ajovy, is $575 a month, the same as Aimovig, a similar monthly injection sold by Amgen Inc and Novartis AG that has been available in the United States since May.

Baby-aspirin risks overwhelm benefits in healthy elderly

In healthy elderly people who never had a heart attack, the widespread practice of taking a baby aspirin every day may do more harm than good, according to a U.S.-Australian study of more than 19,000 volunteers. The trial has "provided convincing evidence that aspirin is ineffective in preserving good health in elderly people without a medical (reason) to be using it," chief author Dr. John J. McNeil of Monash University in Melbourne told Reuters Health in an email.

Even low levels of traffic pollution tied to heart damage

People exposed to even low levels of air pollution are more likely to develop structural changes in the heart that can be a precursor to heart failure, a UK study suggests. While exposure to air pollution has long been linked to an increased risk of heart attacks and strokes, less is known about how pollutants might alter the structure and function of the heart, the study team writes in Circulation.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)

Give Feedback